YAP-Dependent Induction of CD47-Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia-Reperfusion Injury. (22nd June 2021)

• Record Type: Journal Article
• Authors: Yuan, Zenan; Ye, Linsen; Feng, Xiao; Zhou, Tian; Zhou, Yi; Zhu, Shuguang; Jia, Changchang; Li, Haibo; Qiu, Dongbo; Li, Kun; Liu, Wei; Li, Yang; Tang, Hui; Wang, Guoying; Zhang, Qi; Yang, Yang; Chen, Guihua; Li, Hua
• Other Names: Pechanova Olga Academic Editor.
• Is Part Of: Oxidative medicine and cellular longevity. Volume 2021(2021)
• Publication Date: 2021-06-22
• Subjects: Oxidative stress -- Periodicals; Cells -- Aging -- Periodicals; Cells -- Aging; Oxidative stress; Oxidative Stress -- Periodicals; Cell Aging -- Periodicals; Periodicals; 611.0181
• DOI: 10.1155/2021/6617345
• Languages: English
• ISSNs: 1942-0900

Abstract

Abstract : Hepatic ischemia-reperfusion injury (IRI) is the most common cause of liver damage leading to surgical failures in hepatectomy and liver transplantation. Extensive inflammatory reactions and oxidative responses are reported to be the major processes exacerbating IRI. The involvement of Yes-associated protein (YAP) in either process has been suggested, but the role and mechanism of YAP in IRI remain unclear. In this study, we constructed hepatocyte-specific YAP knockout (YAP-HKO) mice and induced a hepatic IRI model. Surprisingly, the amount of serum EVs decreased in YAP-HKO compared to WT mice during hepatic IRI. Then, we found that the activation of YAP increased EV secretion through F-actin by increasing membrane formation, while inhibiting the fusion of multivesicular body (MVB) and lysosomes in hepatocytes. Further, to explore the essential elements of YAP-induced EVs, we applied mass spectrometry and noticed CD47 was among the top targets highly expressed on hepatocyte-derived EVs. Thus, we enriched CD47 + EVs by microbeads and applied the isolated CD47 + EVs on IRI mice. We found ameliorated IRI symptoms after CD47 + EV treatment in these mice, and CD47 + EVs bound to CD172 α on the surface of dendritic cells (DCs), which inhibited DC activation and the cascade of inflammatory responses. Our data showed that CD47-enriched EVs were released in a YAP-dependent manner by hepatocytes, which could inhibit DC activation and contribute to the amelioration of hepatic IRI. CD47 + EVs could be a potential strategy for treating hepatic IRI.